• Text size
  • Send this article to a friend
  • Print this article

ProStrakan signs licence and distribution deal for two key drugs in Canada

ProStrakan Group, the Scottish specialist pharmaceutical company, yesterday announced that it has signed an exclusive licence and distribution agreement with Paladin Labs for its Abstral and Sancuso products in Canada.

Custom byline text: 
DOUGLAS HAMILTON

ProStrakan Group, the Scottish specialist pharmaceutical company, yesterday announced that it has signed an exclusive licence and distribution agreement with Paladin Labs for its Abstral and Sancuso products in Canada.